Cargando…
Potentials of Non-Invasive (18)F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer
The immune checkpoint inhibitors (ICIs), by targeting cytotoxic-T-lymphocyte-associated protein 4, programmed cell death 1 (PD-1), or PD-ligand 1, have dramatically changed the natural history of several cancers, including non–small cell lung cancer (NSCLC). There are unusual response manifestations...
Autores principales: | Liao, Xuhe, Liu, Meng, Wang, Rongfu, Zhang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855498/ https://www.ncbi.nlm.nih.gov/pubmed/35186013 http://dx.doi.org/10.3389/fgene.2021.810011 |
Ejemplares similares
-
The value on SUV-derived parameters assessed on (18)F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer
por: Liao, Xuhe, et al.
Publicado: (2023) -
Dynamic
(18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer
por: Chen, Zhi‐Yong, et al.
Publicado: (2022) -
[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023) -
Diagnostic performance and prognostic value of preoperative (18)F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus
por: Chen, Silu, et al.
Publicado: (2022) -
(18)F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer
por: Wang, Jie, et al.
Publicado: (2023)